Introduction: Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection of vaccinated individuals and indirect protection of unvaccinated individuals by reducing nasopharyngeal (NP) carriage and transmission of vaccine-type (VT) pneumococci. While the indirect effects of PCV vaccination are well described, the PCV coverage required to achieve the indirect effects is unknown. We will investigate the relationship between PCV coverage and VT carriage among undervaccinated children using hospital-based NP pneumococcal carriage surveillance at three sites in Asia and the Pacific. Methods and analysis: We are recruiting cases, defined as children aged 2-59 months admitted to participating hospitals with acute respirato...
Objectives: Pneumococcal conjugate vaccines (PCVs) are effective in reducing pneumococcal disease. W...
INTRODUCTION:Africa harbours a high burden of pneumococcal disease, with associated high mortality r...
BACKGROUND: Community-acquired pneumonia is an important cause of morbidity and mortality in adults....
Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection of vaccinated ...
INTRODUCTION: Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection ...
Background: Pneumococcal disease is an important cause of childhood morbidity and mortality worldwid...
© 2021 Jocelyn Yuen-Wai ChanPneumococcal disease is a leading cause of childhood morbidity and morta...
International audienceIntroduction: Empiric data on indirect (herd) effects of pneumococcal conjugat...
INTRODUCTION: Empiric data on indirect (herd) effects of pneumococcal conjugate vaccines (PCVs) in s...
Introduction Empiric data on indirect (herd) effects of pneumococcal conjugate vaccines (PCVs) in se...
Pneumococcal conjugate vaccine (PCV) is included in the World Health Organization’s routine immuniza...
have shown that pneumococcal capsular polysaccharide vac-cine protects children <2 years of age f...
BACKGROUND: Streptococcus pneumoniae causes substantial morbidity and mortality among children. The ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
OBJECTIVES: Pneumococcal conjugate vaccines (PCVs) are effective in reducing pneumococcal disease. W...
Objectives: Pneumococcal conjugate vaccines (PCVs) are effective in reducing pneumococcal disease. W...
INTRODUCTION:Africa harbours a high burden of pneumococcal disease, with associated high mortality r...
BACKGROUND: Community-acquired pneumonia is an important cause of morbidity and mortality in adults....
Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection of vaccinated ...
INTRODUCTION: Pneumococcal conjugate vaccines (PCVs) prevent disease through both direct protection ...
Background: Pneumococcal disease is an important cause of childhood morbidity and mortality worldwid...
© 2021 Jocelyn Yuen-Wai ChanPneumococcal disease is a leading cause of childhood morbidity and morta...
International audienceIntroduction: Empiric data on indirect (herd) effects of pneumococcal conjugat...
INTRODUCTION: Empiric data on indirect (herd) effects of pneumococcal conjugate vaccines (PCVs) in s...
Introduction Empiric data on indirect (herd) effects of pneumococcal conjugate vaccines (PCVs) in se...
Pneumococcal conjugate vaccine (PCV) is included in the World Health Organization’s routine immuniza...
have shown that pneumococcal capsular polysaccharide vac-cine protects children <2 years of age f...
BACKGROUND: Streptococcus pneumoniae causes substantial morbidity and mortality among children. The ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
OBJECTIVES: Pneumococcal conjugate vaccines (PCVs) are effective in reducing pneumococcal disease. W...
Objectives: Pneumococcal conjugate vaccines (PCVs) are effective in reducing pneumococcal disease. W...
INTRODUCTION:Africa harbours a high burden of pneumococcal disease, with associated high mortality r...
BACKGROUND: Community-acquired pneumonia is an important cause of morbidity and mortality in adults....